Follow this preprint
Development, testing and validation of a SARS-CoV-2 multiplex panel for detection of the five major variants of concern on a portable PCR platform
Bryce J Stanhope, Brittany Peterson, Brittany Knight, Ray Nobles Decadiz, Roger Pan, Phillip Davis, Anne Fraser, Manunya Nuth, Jesse vanWestrienen, Erik Wendlandt, Bruce Goodwin, Chris Myers, Jennifer Stone, Shanmuga Sozhamannan
doi: https://doi.org/10.1101/2022.08.02.22277351
Now published in Frontiers in Public Health doi: 10.3389/fpubh.2022.1042647
Bryce J Stanhope
1Biomeme, Inc., 401 North Broad St, Suite 222 Philadelphia, PA 19108
Brittany Peterson
2MRIGlobal, 425 Dr. Martin Luther King Jr. Boulevard, Kansas City, MO 64110, USA
Brittany Knight
2MRIGlobal, 425 Dr. Martin Luther King Jr. Boulevard, Kansas City, MO 64110, USA
Ray Nobles Decadiz
3Naval Health Research Center (NHRC), San Diego, CA 92152
Roger Pan
3Naval Health Research Center (NHRC), San Diego, CA 92152
Phillip Davis
2MRIGlobal, 425 Dr. Martin Luther King Jr. Boulevard, Kansas City, MO 64110, USA
Anne Fraser
3Naval Health Research Center (NHRC), San Diego, CA 92152
Manunya Nuth
1Biomeme, Inc., 401 North Broad St, Suite 222 Philadelphia, PA 19108
Jesse vanWestrienen
1Biomeme, Inc., 401 North Broad St, Suite 222 Philadelphia, PA 19108
Erik Wendlandt
4Integrated DNA Technologies, 1710 Commercial Park, Coralville, IA 52241, USA
Bruce Goodwin
5Defense Biological Product Assurance Office (DBPAO), Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Enabling Biotechnologies, Frederick, MD 21702, USA
Chris Myers
3Naval Health Research Center (NHRC), San Diego, CA 92152
Jennifer Stone
2MRIGlobal, 425 Dr. Martin Luther King Jr. Boulevard, Kansas City, MO 64110, USA
Shanmuga Sozhamannan
5Defense Biological Product Assurance Office (DBPAO), Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Enabling Biotechnologies, Frederick, MD 21702, USA
6Logistics Management Institute, Tysons, VA 22102, USA

Data Availability
All data produced in the present work are contained in the manuscript and supplemental files. Any additional data are available upon reasonable request to the authors.
Posted August 02, 2022.
Development, testing and validation of a SARS-CoV-2 multiplex panel for detection of the five major variants of concern on a portable PCR platform
Bryce J Stanhope, Brittany Peterson, Brittany Knight, Ray Nobles Decadiz, Roger Pan, Phillip Davis, Anne Fraser, Manunya Nuth, Jesse vanWestrienen, Erik Wendlandt, Bruce Goodwin, Chris Myers, Jennifer Stone, Shanmuga Sozhamannan
medRxiv 2022.08.02.22277351; doi: https://doi.org/10.1101/2022.08.02.22277351
Now published in Frontiers in Public Health doi: 10.3389/fpubh.2022.1042647
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (218)
- Cardiovascular Medicine (3228)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13240)
- Forensic Medicine (19)
- Gastroenterology (889)
- Genetic and Genomic Medicine (5059)
- Geriatric Medicine (470)
- Health Economics (772)
- Health Informatics (3181)
- Health Policy (1128)
- Hematology (423)
- HIV/AIDS (1002)
- Medical Education (468)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4804)
- Nursing (254)
- Nutrition (715)
- Oncology (2475)
- Ophthalmology (701)
- Orthopedics (278)
- Otolaryngology (337)
- Pain Medicine (320)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1277)
- Primary Care Research (550)
- Public and Global Health (7365)
- Radiology and Imaging (1668)
- Respiratory Medicine (969)
- Rheumatology (473)
- Sports Medicine (413)
- Surgery (534)
- Toxicology (69)
- Transplantation (232)
- Urology (199)